S&P 500   4,205.45
DOW   33,093.34
QQQ   348.40
Stock market today: Markets mostly higher after Biden-McCarthy deal on US debt
Laser breakthrough could send stock soaring 2,467% (Ad)
Text released of 99-page bill to raise debt limit, curb spending; lawmakers to review as House eyes Wednesday vote
10 Ways Entrepreneurs Can Navigate a Down Economy
[BREAKING] New "Living Missile" to Replace Nuclear Missiles (Ad)
PwC Australia sidelines 9 directors as leak of tax information investigated
South African president appoints judge to oversee weapons-for-Russia inquiry
[BREAKING] Small Firm Develops World's First Anti-Aircraft Laser (Ad)
Drought-struck Barcelona quenches thirst with costly desalination
Get the Most Out of Remote Meetings and Avoid Meeting Burn Out
S&P 500   4,205.45
DOW   33,093.34
QQQ   348.40
Stock market today: Markets mostly higher after Biden-McCarthy deal on US debt
Laser breakthrough could send stock soaring 2,467% (Ad)
Text released of 99-page bill to raise debt limit, curb spending; lawmakers to review as House eyes Wednesday vote
10 Ways Entrepreneurs Can Navigate a Down Economy
[BREAKING] New "Living Missile" to Replace Nuclear Missiles (Ad)
PwC Australia sidelines 9 directors as leak of tax information investigated
South African president appoints judge to oversee weapons-for-Russia inquiry
[BREAKING] Small Firm Develops World's First Anti-Aircraft Laser (Ad)
Drought-struck Barcelona quenches thirst with costly desalination
Get the Most Out of Remote Meetings and Avoid Meeting Burn Out
S&P 500   4,205.45
DOW   33,093.34
QQQ   348.40
Stock market today: Markets mostly higher after Biden-McCarthy deal on US debt
Laser breakthrough could send stock soaring 2,467% (Ad)
Text released of 99-page bill to raise debt limit, curb spending; lawmakers to review as House eyes Wednesday vote
10 Ways Entrepreneurs Can Navigate a Down Economy
[BREAKING] New "Living Missile" to Replace Nuclear Missiles (Ad)
PwC Australia sidelines 9 directors as leak of tax information investigated
South African president appoints judge to oversee weapons-for-Russia inquiry
[BREAKING] Small Firm Develops World's First Anti-Aircraft Laser (Ad)
Drought-struck Barcelona quenches thirst with costly desalination
Get the Most Out of Remote Meetings and Avoid Meeting Burn Out
S&P 500   4,205.45
DOW   33,093.34
QQQ   348.40
Stock market today: Markets mostly higher after Biden-McCarthy deal on US debt
Laser breakthrough could send stock soaring 2,467% (Ad)
Text released of 99-page bill to raise debt limit, curb spending; lawmakers to review as House eyes Wednesday vote
10 Ways Entrepreneurs Can Navigate a Down Economy
[BREAKING] New "Living Missile" to Replace Nuclear Missiles (Ad)
PwC Australia sidelines 9 directors as leak of tax information investigated
South African president appoints judge to oversee weapons-for-Russia inquiry
[BREAKING] Small Firm Develops World's First Anti-Aircraft Laser (Ad)
Drought-struck Barcelona quenches thirst with costly desalination
Get the Most Out of Remote Meetings and Avoid Meeting Burn Out
NASDAQ:KDNY

Chinook Therapeutics (KDNY) News Today

$23.31
+1.75 (+8.12%)
(As of 05/26/2023 04:00 PM ET)
Compare
Today's Range
$21.50
$23.51
50-Day Range
$18.66
$23.42
52-Week Range
$13.84
$27.44
Volume
552,400 shs
Average Volume
630,687 shs
Market Capitalization
$1.56 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$35.83
Get Chinook Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for KDNY and its competitors with MarketBeat's FREE daily newsletter.



KDNY Media Mentions By Week

KDNY Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

KDNY
News Sentiment

0.43

0.77

Average
Medical
News Sentiment

KDNY News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

KDNY Articles
This Week

10

3

KDNY Articles
Average Week

SourceHeadline
marketbeat.com logoChinook Therapeutics, Inc. (NASDAQ:KDNY) Given Average Recommendation of "Buy" by Brokerages
marketbeat.com - May 29 at 2:17 AM
marketbeat.com logoConnor Clark & Lunn Investment Management Ltd. Sells 51,468 Shares of Chinook Therapeutics, Inc. (NASDAQ:KDNY)
marketbeat.com - May 26 at 8:49 AM
MarketBeat logoBrokers Set Expectations for Chinook Therapeutics, Inc.'s FY2023 Earnings (NASDAQ:KDNY)
americanbankingnews.com - May 26 at 2:02 AM
marketbeat.com logoSwiss National Bank Acquires 5,200 Shares of Chinook Therapeutics, Inc. (NASDAQ:KDNY)
marketbeat.com - May 25 at 4:37 AM
marketbeat.com logoFY2023 EPS Estimates for Chinook Therapeutics, Inc. (NASDAQ:KDNY) Reduced by Analyst
marketbeat.com - May 24 at 6:19 AM
markets.businessinsider.com logoAnalysts Offer Insights on Healthcare Companies: Tandem Diabetes Care (TNDM), Chinook Therapeutics (KDNY) and Zoetis (ZTS)
markets.businessinsider.com - May 23 at 12:44 PM
benzinga.com logoSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Chinook Therapeutics, Inc. - KDNY
benzinga.com - May 21 at 9:25 PM
benzinga.com logoChinook Shareholder Notice
benzinga.com - May 21 at 11:25 AM
marketbeat.com logoVictory Capital Management Inc. Has $30.48 Million Stock Position in Chinook Therapeutics, Inc. (NASDAQ:KDNY)
marketbeat.com - May 21 at 5:52 AM
seekingalpha.com logoChinook Therapeutics: Travere's Pain Is Chinook's Gain
seekingalpha.com - May 19 at 2:59 PM
benzinga.com logoChinook Investor Alert
benzinga.com - May 19 at 12:31 AM
benzinga.com logoGlancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Chinook Therapeutics, Inc. (KDNY) on Behalf of Investors
benzinga.com - May 18 at 2:29 PM
MarketBeat logoChinook Therapeutics (NASDAQ:KDNY) Shares Down 7.8%
americanbankingnews.com - May 18 at 7:18 AM
benzinga.com logoINVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Chinook Therapeutics, Inc. (KDNY) on Behalf of Investors
benzinga.com - May 17 at 10:20 PM
msn.com logoChinook defended at Guggenheim following short report
msn.com - May 17 at 12:19 PM
businesswire.com logoINVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Chinook Therapeutics, Inc. and Encourages Investors with Losses to Contact the Firm
businesswire.com - May 17 at 2:18 AM
in.investing.com logoChinook Therapeutics plunges as Muddy Waters alleges it 'systemically manipulated research findings'
in.investing.com - May 16 at 4:12 PM
reuters.com logoMuddy Waters takes short position in drugmaker Chinook - report
reuters.com - May 16 at 4:12 PM
markets.businessinsider.com logoFamed Short Seller Muddy Waters Targets Chinook Therapeutics, Points To Drug Data Questions
markets.businessinsider.com - May 16 at 4:12 PM
finance.yahoo.com logoChinook Therapeutics Announces Partnership with Ionis to Develop Antisense Therapy for Rare, Severe Chronic Kidney Disease
finance.yahoo.com - May 16 at 10:00 AM
MarketBeat logoChinook Therapeutics, Inc. (NASDAQ:KDNY) Expected to Earn FY2023 Earnings of ($3.19) Per Share
americanbankingnews.com - May 14 at 3:20 AM
MarketBeat logoWedbush Weighs in on Chinook Therapeutics, Inc.'s Q2 2023 Earnings (NASDAQ:KDNY)
americanbankingnews.com - May 14 at 1:58 AM
MarketBeat logoQ2 2023 EPS Estimates for Chinook Therapeutics, Inc. (NASDAQ:KDNY) Decreased by Analyst
americanbankingnews.com - May 14 at 1:58 AM
MarketBeat logoQ1 2024 Earnings Forecast for Chinook Therapeutics, Inc. Issued By Wedbush (NASDAQ:KDNY)
americanbankingnews.com - May 13 at 7:04 AM
marketbeat.com logoFY2023 Earnings Forecast for Chinook Therapeutics, Inc. (NASDAQ:KDNY) Issued By William Blair
marketbeat.com - May 12 at 9:40 AM
marketbeat.com logoSG Americas Securities LLC Has $210,000 Stock Position in Chinook Therapeutics, Inc. (NASDAQ:KDNY)
marketbeat.com - May 12 at 4:33 AM
msn.com logoRecap: Chinook Therapeutics Q1 Earnings
msn.com - May 12 at 12:52 AM
MarketBeat logoHC Wainwright Increases Chinook Therapeutics (NASDAQ:KDNY) Price Target to $32.00
americanbankingnews.com - May 11 at 6:32 AM
markets.businessinsider.com logoChinook Therapeutics (KDNY) Receives a Buy from Wedbush
markets.businessinsider.com - May 10 at 3:39 PM
msn.com logoChinook Therapeutics GAAP EPS of -$0.85, revenue of $1.8M
msn.com - May 9 at 8:25 PM
finance.yahoo.com logoChinook Therapeutics Reports First Quarter 2023 Financial Results and Provides Corporate Updates
finance.yahoo.com - May 9 at 8:25 PM
MarketBeat logoChinook Therapeutics, Inc. (NASDAQ:KDNY) Receives $36.86 Average Target Price from Brokerages
americanbankingnews.com - May 7 at 2:20 AM
finance.yahoo.com logoChinook Therapeutics Announces Upcoming Presentations and Investor Conference Call at the 60th European Renal Association (ERA) Congress
finance.yahoo.com - May 5 at 6:41 PM
marketbeat.com logoChinook Therapeutics, Inc. (NASDAQ:KDNY) Receives Average Recommendation of "Buy" from Analysts
marketbeat.com - May 4 at 2:38 AM
msn.com logoCantor Fitzgerald Reiterates Chinook Therapeutics (KDNY) Overweight Recommendation
msn.com - May 3 at 12:57 PM
msn.com logoGuggenheim Maintains Chinook Therapeutics (KDNY) Buy Recommendation
msn.com - May 2 at 11:01 AM
MarketBeat logoChinook Therapeutics (NASDAQ:KDNY) PT Lowered to $35.00 at Guggenheim
americanbankingnews.com - May 2 at 7:36 AM
marketbeat.com logoFrazier Life Sciences Management L.P. Purchases 80,000 Shares of Chinook Therapeutics, Inc. (NASDAQ:KDNY)
marketbeat.com - May 1 at 5:21 AM
MarketBeat logoChinook Therapeutics, Inc. (NASDAQ:KDNY) CEO Eric Dobmeier Sells 23,800 Shares
americanbankingnews.com - April 27 at 6:44 AM
msn.com logoUnusual Call Option Trade in Chinook Therapeutics (KDNY) Worth $50.00K
msn.com - April 24 at 6:15 PM
MarketBeat logoChinook Therapeutics, Inc. (NASDAQ:KDNY) Short Interest Update
americanbankingnews.com - April 22 at 6:56 AM
MarketBeat logoDavis Jerel Sells 295,808 Shares of Chinook Therapeutics, Inc. (NASDAQ:KDNY) Stock
americanbankingnews.com - April 22 at 4:24 AM
seekingalpha.com logoChinook: CHK-336 Trial Pause Creates Buying Opportunity, All Eyes On IgAN Readout
seekingalpha.com - April 20 at 3:02 AM
MarketBeat logoChinook Therapeutics (NASDAQ:KDNY) Trading Up 3.2%
americanbankingnews.com - April 14 at 6:42 AM
MarketBeat logoChinook Therapeutics, Inc. (NASDAQ:KDNY) Given Average Rating of "Buy" by Analysts
americanbankingnews.com - April 14 at 2:20 AM
finanznachrichten.de logoChinook Therapeutics, Inc.: Chinook Therapeutics Announces the Appointment of Robert W. Azelby to its Board of Directors
finanznachrichten.de - April 13 at 1:14 PM
finance.yahoo.com logoChinook Therapeutics Announces the Appointment of Robert W. Azelby to its Board of Directors
finance.yahoo.com - April 13 at 8:13 AM
finance.yahoo.com logoChinook Therapeutics Announces Voluntary Pause in Dosing of CHK-336 in Ongoing Phase 1 Clinical Trial in Healthy Volunteers
finance.yahoo.com - April 11 at 10:16 AM
uk.finance.yahoo.com logoInvestors push Chinook Therapeutics (NASDAQ:KDNY) 4.2% lower this week, company's increasing losses might be to blame
uk.finance.yahoo.com - April 7 at 2:45 PM
MarketBeat logoChinook Therapeutics, Inc. (NASDAQ:KDNY) Insider Andrew James King Sells 5,000 Shares
americanbankingnews.com - April 6 at 7:54 AM
Get Chinook Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for KDNY and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

This page (NASDAQ:KDNY) was last updated on 5/29/2023 by MarketBeat.com Staff

My Account -